Company intelligence
Flagship Pioneering
We are a biotechnology company that invents and builds platform companies that change the world.
About Flagship Pioneering
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, and Tessera Therapeutics.
Verified activity
Signals from Flagship Pioneering
9 published signals
Products & Services
Flagship Pioneering is launching Pioneering Abundance, a new initiative built around producing resources in abundance at a sustainable scale.
Reported by Flagship Pioneering
Research & Knowledge
Flagship Pioneering's Flagship Origination Partner Scott Lipnick shared his perspective for The Labs Report on the gap between disease detection and when it begins.
Reported by Flagship Pioneering
Strategy & Corporate Development
Flagship Pioneering is working across an ecosystem of first-in-class assets to de-risk translational and regulatory pathways.
Reported by Magda Papadaki
Presence & Recognition
Flagship Pioneering featured Jonah Cool, Avak Kahvejian, Lovisa Afzelius, Ryan Rapp, and Bram Govaerts in a LinkedIn post discussing Polyintelligence.
Reported by Flagship Pioneering
Research & Knowledge
Flagship Pioneering uses AI to reveal patterns in viral proteins that have remained hidden for billions of years.
Reported by Lovisa Afzelius
Research & Knowledge
Flagship Pioneering's Flagship Origination Partner Scott Lipnick discusses moving from treating disease to preventing it in The Labs Report
Reported by Flagship Pioneering
Presence & Recognition
Flagship Pioneering founder and CEO Noubar Afeyan joined Liz Claman on Fox Business Network's The Claman Countdown to discuss Moderna and Merck's mRNA-based cancer therapy and its Phase 3 results.
Reported by Flagship Pioneering
Presence & Recognition
Flagship Pioneering employee Noubar Afeyan joined Liz Claman on Fox Business Network to discuss the Moderna Merck clinical trial and its implications for cancer treatment.
Reported by Noubar Afeyan
People
Flagship Pioneering was named to the Fierce 50 list by Fierce Pharma for its Founder and CEO Noubar Afeyan
Reported by Flagship Pioneering